Public trial registry of the CCC-Munich

Trial AGO-OVAR 2.15 / AURELIA

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
AGO-OVAR 2.15 / AURELIA
World
Full title
:

Eine multizentrische, offene, randomisierte, zweiarmige Phase III Studie mit Bevacizumab plus Chemotherapie versus Chemotherapie als Monotherapie bei Patientinnen mit platin-resistentem epithelialen Ovarial-, Tuben- oder primären Peritonealkarzinom

World
EudraCT number
:
World
NCT number
:
World
Responsible organization
:
Frauenklinik GH, Telefon: 089440076800
Indications
Classification Code Description
- Gynecological tumor
Trial design
World
Trial type
:
Interventional
World
Blinding type
:
Open
World
Phase
:
III
Status
World
Status
:
Trial finished
Votes
World
Institutional review board - vote
:
Unknown
Initiiation & lock
World
Date of lock (planned / actual)
:
2014-07-31 / Unknown
Participants
Function Prename Surname Organization
World Principal Investigator Alexander Burges Keine Organisationseinheit angegeben Magnifier